Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Exosomes & Single Cell Analysis Summit

Steve Soper's Biography



Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, Adjunct Professor, Ulsan National Institute of Science & Technology, William H. Pryor Emeritus Chair of Chemistry, The University of Kansas

Professor Soper is currently Foundation Distinguished Professor in Chemistry and Mechanical Engineering at the University of Kansas, Lawrence. Prof. Soper also holds an appointment at Ulsan National Institute of Science and Technology in Ulsan, South Korea, where he is a World Class University Professor. He is also serving as a Science Advisor for a number of major worldwide companies. Prof. Soper is currently the Editor of the Americas for the Analyst and on the Editorial Board for Journal of Fluorescence and Journal of Micro- and Nanosystems. Prof. Soper is also serving as a permanent Member of the Nanotechnology study panel with the National Institutes of Health.

As a result of his efforts, Prof. Soper has secured extramural funding totaling >$93M and has published over 245 peer-reviewed manuscripts (h index = 62) and is the author of 14 patents. He is also the founder of a startup company, BioFluidica, which is marketing devices for the isolation and enumeration of circulating tumor cells. His list of awards includes Chemical Instrumentation by the American Chemical Society, the Benedetti-Pichler Award for Microchemistry, Fellow of the AAAS, Fellow of Applied Spectroscopy, Fellow of the Royal Society of Chemistry, R&D 100 Award, Distinguished Masters Award at LSU and Outstanding Scientist/Engineer in the state of Louisiana in 2001. Finally, Prof. Soper has granted 44 PhDs and 6 MS degrees to students under his mentorship. He currently heads a group of 15 researchers.

Steve Soper Image

Integrated Microfluidic System for Single Cell Analysis of Circulating Tumor Cell Sub-populations with Divergent Phenotypes

Thursday, 18 September 2014 at 10:15

Add to Calendar ▼2014-09-18 10:15:002014-09-18 11:15:00Europe/LondonIntegrated Microfluidic System for Single Cell Analysis of Circulating Tumor Cell Sub-populations with Divergent PhenotypesExosomes and Single Cell Analysis Summit in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

While metastatic disease causes ~90% of all cancer related deaths, determining the role of various cancer cells, either from the primary tumor or those in circulation (circulating tumor cells, CTCs), in the metastatic process has been difficult due to the continuum of phenotypes they possess and/or the rare nature of these cells, especially CTCs. To assist in studies based on the use of rare CTCs that may be involved in metastasis, an integrated microfluidic system was designed, fabricated and evaluated, which could select multiple types of cells, including cells that have an epithelial phenotype and those that possess the ability to  digest the extracellular matrix (ECM).


Add to Calendar ▼2014-09-18 00:00:002014-09-19 00:00:00Europe/LondonExosomes and Single Cell Analysis SummitExosomes and Single Cell Analysis Summit in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com